Synergistic antibacterial activity of cefotaxime and the penem HRE 664 in an improved in vitro model simulating serum and tissue pharmacokinetics.
Isert
D
D
Pharma Research, Hoechst AG, Frankfurt/M., FRG.
Klesel
N
N
Markus
A
A
Seibert
G
G
Schrinner
E
E
D000900:Anti-Bacterial Agents / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology; D002439:Cefotaxime / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology*; D004357:Drug Synergism; D005285:Fermentation; D007700:Kinetics; D007769:Lactams / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology*; D008954:Models, Biological; D014018:Tissue Distribution
D000900:Anti-Bacterial Agents; D007769:Lactams; C053338:HRE 664; D002439:Cefotaxime